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ABSTRACT 
Proliferating cell nuclear antigen (PCNA) is a DNA polymerase δ auxiliary protein 
during cell cycle. However, PCNA is also present in quiescent cells undergoing DNA 
repair. This study investigates the expression of PCNA in CNS macrophages of SIV 
infected Rhesus macaque and examines the presence of PCNA in monocytes prior to 
differentiation into CNS macrophages. Accumulation of macrophages in the SIV infected 
brain, together with the creation of multinucleated giant cells (MNGC), form SIV lesions, 
which lead to neurological disorders. From the twelve animals used in this study, four 
were analyzed by flow cytometry to detect PCNA expression in monocytes, but no 
expression of PCNA was detected. Peripheral blood mononuclear cells (PBMC) of five 
animals were also analyzed using cytospin preparations to confirm results obtained by 
flow cytometry. The study did not find induction of PCNA mRNA by qRT-PCR in 
infected animals. Animals that developed SIVE were analyzed by immunohistochemistry 
to identify PCNA in recently immigrated macrophages. Together results suggest that 1) 
PCNA is not expressed in monocytes; 2) PCNA in monocyte/macrophages is induced in 
 SIV infected animals and it is not associated with cell cycle; 3) Recently immigrated 
monocytes of CNS are PCNA negative and 4) majority PCNA+ macrophages in the SIVE 
lesions are perivascular macrophages.
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INTRODUCTION 
 
AIDS and HIV-associated encephalitis 
The human immunodeficiency virus (HIV) is a retrovirus that targets cells of the 
immunosystem and is the cause of the acquired immunodeficiency syndrome (AIDS), a 
disease that affects about 33 million people worldwide (52). As a lentivirus, HIV contains 
reverse transcriptase to make its own cDNA in the host cell. Once the cDNA is made in 
the cytoplasm, it is transported to the nucleus together with pre-integration complexes 
where it is incorporated into the host genome. Once in the genome, viral proteins can be 
made using host transcriptional and translational mechanisms until whole viruses are 
newly made and leave the cell for infection of a new cell (9, 10, 33).  One of the viral 
proteins that are made in the host cell is a 28kD capsid protein (SIV-p28), which is used 
in this study to detect productive viral infection. 
HIV can be latent for many years in a patient, however in later stages of the 
disease, patients can develop a collection of neurological symptoms termed HIV-
associated neurocognitive disorder (HAND) or HIV-associated dementia (HAD) 
(52).These disorders are characterized by accumulative macrophages in the central 
nervous system (CNS) leading to encephalitis (18, 19). Many studies have attempted to 
distinguish markers associated with the development of HAD, such as CD4+ counts (50), 
elevated cerebrospinal fluid (CSF) viral load (16) and magnetic resonance spectroscopy 
(MRS) (15, 46, 67). Similar to humans, upon SIV infection, Rhesus macaque 
macrophages accumulate in the CNS. Recently two studies by our group identified that 
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an increase of monocyte turnover is correlated with rapid development of AIDS (23) and 
severity of encephalitis (7). Based on the accumulation of macrophages in HIV 
encephalitis (HIVE) and in SIV encephalitis (SIVE) and the fact that monocyte turnover 
is associated with disease, monocytes and macrophages are of great interest in the 
development of disease. This thesis focuses on monocytes and monocyte-derived 
macrophages within the CNS of monkeys with SIVE, and investigates PCNA expression 
with viral infection. 
 
 Monocytes and monocyte-derived macrophages  
Monocytes are blood mononuclear cells derived from monoblasts in the bone 
marrow that participate in innate immune responses. One of their functions is to replenish 
macrophages and populations of dendritic cells in tissues (11, 12, 58, 61). 
The blood brain barrier (BBB), made of endothelial cells with tight junctions, 
prevents free virus to access the CNS (22, 47). Knowing that macrophages  in 
HIVE/SIVE  animals are infected by HIV/SIV (31, 32, 66), it is thought that monocytes 
behave as a “Trojan horse” bringing the virus to the CNS (48, 53). In this thesis it is 
hypothesized that in SIV infected animals, monocytes express PCNA prior to enter the 
CNS becoming a source of PCNA positive cells in this tissue. 
To select populations of monocytes within blood, expression levels of specific 
myeloid markers are used. CD14, a LPS receptor and CD16, a FcϒIII receptor have been 
used to identify monocytes in peripheral blood mononuclear cells and to distinguish them 
into three different populations (CD14+CD16-; CD14+CD16+; CD14-CD16+) (43, 71). 
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The presence of HLA-DR, the major histocompatibility complex, and the lack of 
lymphocyte markers such as CD3, CD8 or CD20, facilitate the identification of 
monocytes in the blood.  
For the study of monocyte-derived macrophages in the CNS, this study used 
known macrophages markers such as: 1) CD163, a scavenger receptor that facilitates the 
recycling of hemoglobin residues (19, 30) and is a marker of perivascular macrophages 
(cells located in the perivascular space of cerebral vessels at the intersection between the 
brain parenchyma and blood) (31); and 2) Mac387, a calcium-binding protein which is 
seen mostly in recently tissue-infiltrated macrophages (45).  
In order to identify the functions and effects of the high number of tissue 
macrophages in the brain, studies have analyzed HIVE/SIVE lesions and the cellular 
response of these cells (2, 20, 23, 26, 30, 32, 49, 65, 67, 68). In animals with SIV 
encephalitis, CD14 and CD163 positive macrophages are found to be the major cell type 
in SIV lesions where they can contain SIV RNA (30, 66) and therefore are productively 
infected. Similar results in the CNS of HIV infected humans parallel observations in SIV 
infected monkeys (19). These studies highlight the importance of macrophages in the 
development of SIVE. This thesis investigates whether PCNA+ macrophages are recently 
migrated monocytes or mature resident macrophages in order to complete the 
identification of these cells in the CNS.  
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      Function and importance of PCNA  
PCNA is a homotrimer protein found in all phases of the cell cycle (6). 
Occasionally PCNA is found in cells in G0 but this expression is associated either to the 
long half-life of the protein (36) suggesting a non-functional protein or associated to 
DNA repair upon DNA damage (40, 57). PCNA is found in replication forks assisting 
DNA polymerase to slide through DNA strands during DNA replication (5, 8, 41). As 
reviewed by Moldovan et al (41), mismatches of nucleotide pairing, deletions or other 
misplacements occasionally occur during the process of DNA replication, and PCNA 
functions to ensure the progression of the replication fork by allowing these DNA 
damage spots to be repaired after DNA replication (37, 64). In order to maintain the 
replication process despite these errors, PCNA is involved in bypass replication in which, 
upon DNA damage, PCNA is monoubiquitinated to recruit translesion polymerases to 
substitute polymerase δ to continue the replication on the damaged area. The fast switch 
of polymerases allows replication to move forward and starts the pathway for post-
replication repair (37). Due to its activity in DNA replication, PCNA has been considered 
as a proliferation marker for years (21, 29, 34). But, PCNA is not only involved in DNA 
replication during cell cycle, but also DNA repair response of quiescent differentiated 
cells (40, 57) and at sites of DNA repair of genes that are actively being transcribed (1), 
thus making PCNA an unreliable marker for proliferating cells (3, 25, 42) 
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PCNA expression in the Central Nervous System (CNS) of animals with 
HIVE/SIVE 
PCNA expression within the CNS is associated with SIV infected macrophages 
(19, 66). Moreover, in HIV infected humans, the same pattern is seen (19). In order to 
explain the function of PCNA in brain macrophages, previous studies used the cell cycle 
marker Ki-67 to ask whether those cells returned to cell cycle. However, the Ki-67 
staining showed only few scattered positive cells in CNS, none of which were PCNA 
positive (19, 66). These results suggest that factors other than cell cycle are operative, 
inducing PCNA expression in CNS of SIV/HIV infected subjects. 
The expression of PCNA in macrophages does not occur only in the CNS. PCNA 
expression has been observed in the progression of many diseases. For instance, it was 
observed that PCNA expression in peripheral blood mononuclear cells (PBMC) correlate 
with the stages of malignant lymphoma (54) and the increase of PCNA expression is 
suggested to be induced by cytokines produced by tumor cells. Moreover, PCNA mRNA 
has been shown to increase upon HPV infection (39), suggesting an association with 
infection and PCNA expression.  
PCNA is expressed in macrophages of humans with glomerulonephritis, and in 
cultured microglia in response to the macrophage colony-stimulating factor (M-CSF) (28, 
38). All these studies demonstrate that there are multiple factors that can induce PCNA 
expression in non-cycling cells such as macrophages: DNA replication, DNA repair, cell 
stimulation by cytokines and viral infection. This study will focus in finding if viral 
infection induces PCNA expression in monocytes and if PCNA induction of monocytes 
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and is associated with cell cycle. 
 
Markers of DNA replication and cell cycle  
One of the questions that this study addresses is if viral infection induces PCNA 
expression. In addition to the use of antibodies for viral protein (SIV-p28) or viral RNA, 
to identify if infection induces PCNA, this study uses markers of DNA replication and 
cell cycle in order to investigate if PCNA function is relative to DNA replication in 
macrophages. Five’ bromo 2’ deoxyuridine (BrdU) incorporation is used to identify DNA 
replication and Ki-67 to identify cells in cell cycle. BrdU, a thymidine homologue is used 
to detect cells in S phase as it is incorporated during DNA replication (42). Ki-67 is a 
protein found consistently present in cycling cells and absent in G0 or terminally 
differentiated cells (51). Together markers for monocyte/macrophage these proliferating 
cell markers can be used to determine if PCNA positive cells are cycling (42, 51).  
 
Thesis Hypotheses  
Based on the studies described above (19, 66), CNS macrophages are PCNA 
positive in SIV/HIV infected subjects. Here, it is hypothesized that: 1) Prior to infiltration 
into the brain, monocytes express PCNA at the later stage of AIDS and this expression 
might lead to cell cycle re-entrance. 2) PCNA in CNS macrophages is induced by viral 
infection and this induction is not associated with cell cycle or cell differentiation. 
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Specific Aims 
1) To test whether PCNA expression is induced on monocytes during AIDS 
progression and to investigate if monocytes return to cell cycle after infection. 
Monocytes give rise to CNS macrophages, which can be PCNA positive cells 
with infection. We will analyze if monocytes express PCNA prior to differentiation into 
macrophages, using flow cytometry and markers to identify monocytes within PBMC. 
Since PCNA is known to be involved in DNA replication, we will assess if monocytes 
return to cell cycle after infection using flow cytometry from SIV infected monkeys and 
PCNA and Ki-67 antibodies to detect cycling cells in monocytes 
 
2) To analyze CNS macrophages, investigating whether PCNA positive cells are 
in cell cycle, recently infiltrated or are mature, resident cells. 
Previous studies showed that PCNA and Ki-67 did not co-localized in CNS cells, 
indicating that the PCNA+ macrophages are not cycling in situ (17, 66). However, it is 
still unknown if PCNA is induced as macrophages differentiate within the CNS.  This 
study will identify if PCNA positive macrophages are recently infiltrated, using 
immunohistochemical stains for MAC387 (marker of recently infiltrated 
monocyte/macrophage) and BrdU. Together with previous studies, this thesis will reveal 
a clear profile of PCNA positive macrophages, their phenotype and origins.
8|Page 
MATERIALS AND METHODS 
 
 Animals used in this study and BrdU injections. 
A complete list of animals can be found at Table 1. In order to identify PCNA 
positive monocytes in PBMC by cytospin preparations, five Rhesus macaques were used: 
Animal numbers 28807, 16805, 5505, 16805 and 24496. Animals were infected with 
SIVmac521 (20ng of p27) by intravenous injection at day zero and were depleted of 
CD8+ cells by injection of anti-CD8 antibody cM-T807 administered s.c. (10mg/kg) at 6 
days post infection and i.v. (5mg/kg) at 8 and 12 days post-infection. These animals were 
injected with 60 mg BrdU/kg at days -9, 7 and 26 post-infection (pi) and 48h prior to 
necropsy. Another set of animals (n=4) were used for the detection of PCNA mRNA in 
monocytes (animal # 3209, 3709, 6108 and 6608). Blood was analyzed at days 0, 13, 20 
and 55 pi. Animals 3209 and 3709 were injected with BrdU on days 7, 21 pi and 24h 
prior to the necropsy. Animals 6108 and 6608 were injected with BrdU at days 12, 26, 54 
post infection and 24h prior to necropsy. 
 Histology was performed in animals that developed SIVE: 24496, 5505, and 
animal DB79. SIVE is defined by accumulation of macrophages, presence of 
multinucleated giant cells and neuronal degeneration. Sections from occipital cortex 
(OC), thalamus (TH), pre-frontal cortex (PFC), parietal cortex (PC), frontal cortex (FC) 
and temporal cortex (TC) were used for histological analysis. 
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 For in vitro analysis of BrdU incorporation, monocyte-derived macrophages were 
cultured from isolated CD14+ cells of uninfected animals (Animal# 320-08, 358-08 and 
360-08). Cells were cultured in conditions described below.  
 
 Flow cytometry staining 
For flow cytometric analysis, PBMC were isolated by Ficol-histopaque gradient 
after diluting the blood 1:3 with Harris Buffer Salt Solution (HBSS). PBMC were 
collected and cells were incubated with 3ml of ACK buffer for 3 minutes to lyse red 
blood cells (RBC). Cells were washed with DPBS, and 1x106 cells were added to flow 
tubes for staining and incubated on ice for 10min. For fixation and permeabilization, 
methanol at -20°C was added drop by drop while vortexing and cells were incubated for 
45 minutes on ice. The cells were then washed twice with DPBS and incubated with the 
surface and intracellular antibodies together for 30min at room temperature (RT). 
Antibodies used in this study were: anti-HLA-DR-PerCp-Cy5.5 (clone L243), anti-
CD14-Pacific blue (clone M5E2) (BD Biosciences), anti-Ki-67-PE (clone B56; BD 
Biosciences), anti-CD3 Alexa 700, anti-PCNA FITC, anti-Ki-67 PE and anti-BrdU APC. 
After antibody incubation, cells were washed with DPBS, ressuspended in 2% 
paraformaldehyde and stored at 4°C until analyzed by flow cytometry. 
 
  Cytospin Preparations 
Peripheral blood mononuclear cells were retrieved from whole blood of normal 
and SIV infected animals 1x105 cells were added per cytofunnel (Thermo Scientific) and 
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centrifuged at 1350 rpm onto slides. Cells on slides were dried overnight and stored at -
80°C until staining. 
 
 Cell culture conditions 
A CEM cell line, kindly provided by Howard Fox (University of Nebraska 
Medical Center), was used as a positive control for PCNA staining in cytospins and flow 
cytometry. CEM were cultured with RPMI (GIBCO), 10% FBS, 10mM Hepes and 
Streptomycin and Penicillin (GIBCO). Cells were maintained in 37°C incubator at 5% 
CO2 and 78% humidity. 
Monocyte-derived macrophages were cultured in DMEM (Cellgro) or RPMI 
(GIBCO) containing 0.1g/L of Sodium Pyruvate and penicillin and streptomycin. BrdU 
was added to the media to a final concentration of 10uM (BD Pharmigen) and cells were 
incubated for 5 days. 
 
 Staining of cytospin preparations and chamber slides 
Cytospin preparations of CEM cells and PBMC were thawed at RT and fixed with 
100 ul of Cytofix/Cytoperm™ buffer (BD Biosciences) for 20 min at RT. Cells were 
washed with Perm wash for 2 minutes and then incubated with 100 ul of BD Cytoperm 
Plus™ buffer for 10 min on ice, before a second wash. Next cells were incubated with 
DNase (300µg/ml)) for 1hr at 37°C. After incubation, cells were washed again with Perm 
wash and after addition of endogenous peroxidase block (DAKO) for 5 min at RT, were 
washed with TBS 0.05% tween twice for 5 minutes. Next, cells were incubated with 
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protein block (DAKO) for 10 min at RT in preparation to addition of the antibody. PCNA 
clone PC10 (Millipore) (1:1000) or/and IgG2a isotype control (DAKO) (1:500) was 
prepared in antibody diluent (DAKO) and added to the cells for 1h at RT. At the end of 
incubation, cells were washed twice with TBS 0.05% tween for 5 min and incubated for 
30 min with horseradish peroxidase (HRP) polymer specific for mouse antibodies. After 
washing cells twice with TBS Tween, an HRP substrate was added together with DAB 
for the development of the color. The reaction was stopped by rinsing cells in water for 5 
min. Cells were incubated in hematoxylin of Harris (SIGMA) (1:10) for 5 seconds, rinsed 
with dH2O, de-hydrated in a gradient series of ethanol and xylene and mounted with 
vectamount (VECTOR). 
 For double staining using monocyte and lymphocyte specific antibodies, mouse 
anti-human CD14 antibody clone AML 2-23 (Medarex,) and rabbit anti-human CD3 
antibody (DAKO) were added respectively to the cells using the same protocol used for 
PCNA staining. For staining of monocyte-derived macrophages in chamber slides, cells 
were washed twice with PBS and fixed with cytofix/cytoperm for 20 min at RT. After 
primary antibody was added, cells were washed with buffer containing PBS, 0.2% of Fish 
Skin Gelatin (Sigma) and 0.1% of Triton twice for 5 minutes. Cells were incubated for 5 
minutes with PBS-FSG and then incubated with the secondary antibody mouse anti-goat 
IgG2a AF488 (Molecular Probes-Invitrogen) for 40min at RT. Cells were washed with 
PBS-FSG-Triton twice for 20 min and with PBS-FSG for 10min at RT. The cells were 
covered with PBS-FSG and 10% of normal goat serum (GIBCO) for 40 min at RT and 
the rat anti-BrdU  (NovusBio) was added at the dilution 1:25 and cells were incubated 
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overnight.  Cells were washed twice with PBS-FSG-Triton for 20 min and once with 
PBS-FSG for 10 min. The mouse anti-rat IgG2a AF568 (Molecular Probes-Invitrogen) 
was added to the cells for incubation for 40 min at RT. Cells were washed with PBS-
FSG-Triton and PBS-FSG twice for 20 min and once for 10min respectively before 
rinsing with dH2O and mounting slides with Vectashield with DAPI (Vector). 
 
  Staining of Brain Sections 
Brain sections from infected Rhesus were fixed in formalin and paraffin 
embedded at Harvard Primate Center. 5-8um sections were cut and mounted onto glass 
slides for immunohistochemical analysis. Sections were re-hydrated by incubation in 
xylene and in a decreasing series of ethanol followed by 5 min dH20 incubation. For 
antigen retrieval, sections were microwaved in a solution of citrate buffer (pH 6) for 20 
min.  For single staining, sections were incubated in TBS 0.05% Tween for 5 min, buffer 
was blotted off and the sections were incubated with peroxidase block (DAKO) for 5 min 
followed by wash in TBS Tween. The protocol followed for the completion of this 
staining was the same used for PCNA in cytospins as described above. For double 
staining where both antibodies were made in mouse, a Polink-DS-MM kit  (IHC world) 
protocol was followed. 
 
 
 
 
13|Page 
 Antibodies used for Immunohistochemistry (IHC) and / or Immuno 
fluorescence (IF) in brain sections. 
Antibodies used for brain staining were: mouse anti-human PCNA (clone PC10, 
DAKO), mouse monoclonal anti-BrdU (clone Bu20a, DAKO), mouse anti-human 
Mac387 (clone Mac387, DAKO) mouse anti-p28 (clone MX-0322, Microbix 
biosystems), mouse anti-human CD68 (clone Kp1, DAKO), mouse anti-human CD163 
(clone EDHu-1, Serotec).  
 The SIV RNA probe used in this study was a riboprobe cocktail; consisting of 
seven different SIV probes spanning the majority of the SIVmac239  genome (Lofstrand 
Lab, Ltd). 
 
 Real Time PCR for PCNA  
 Real Time PCR was done using Step One – (Applied Biosystems) and results 
controlled with the continuous expressed housekeeping gene glyceraldehyde 3-
phosphate dehydrogenase (GAPDH). Primers for GAPDH are 5’- GCA CCA CCA 
ACT GCT TAG CAG - 3’ forward, 5’ - TCT TCT GGG TGG CAG TGA TG - 3’ 
reverse, 5’ - /56-FAM/TCG TGG AAG GAC TCA TGA CCA CAG TCC /36-TAMSp/ -
3’ probe. Primers for PCNA are 5’ – GCG GAG CAG AGT GGT AGT TC – 3’ forward, 
5’ – GCC TCC AAC ACC TTC TTC AG -3’ reverse and 5’ - /56-FAM/ ACC GGC TAC 
ACT TTC CTC CT/36-TAMSp/ -3’ probe. 
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RESULTS 
 
 Monocytes do not express PCNA in SIV infected animals 
Four SIV infected animals were analyzed by flow cytometry and the machine was 
compensated using comp beads (BD Biosciences) with antibodies alone. The analysis of 
monocytes followed the gating strategy shown in Figure 1. Monocytes were selected 
within PBMC through gating forward versus-side-scatter and cells that were HLA-
DR+CD3- were detected. After identifying the CD14+ cells, they were analyzed for 
presence of PCNA and Ki-67. CD16+ monocytes were not analyzed in this study because 
methanol altered the fluorescence of CD16. 
Analysis of blood from uninfected animals showed no expression of PCNA in 
CD14+ monocytes (Figure 2A), moreover in SIV infected animals, no PCNA expression 
was detected during disease progression (days 13, 20 and 55pi) (Figure 2A, 2C, 2E). As a 
positive control for PCNA staining, lymphocytes analyzed at the same time points were 
positive (Figure 2B, 2D, 2F). In addition, the CEM cell line was also used as a positive 
control for the staining (Figure 3).  Cytospin preparations of PBMC from five additional 
SIV infected animals were stained for PCNA and CD3, and results confirmed that PCNA 
is not detected in CD14+ cells (data not shown) but is detected in CD3+ cells  (Figure 4).  
In addition to the lack of PCNA induction in monocytes from SIV infected 
animals, these cells were also Ki-67 negative (Figure 5). These data suggest that 
monocytes from SIV infected animals do not return to cell cycle and do not contain 
detectable levels of PCNA. 
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Following the observation that monocytes are negative for PCNA expression is 
throughout disease, PCNA mRNA was analyzed in a study of three SIV infected animals. 
For this, CD14+ monocytes from infected animals were isolated, analyzed by qRT-PCR 
and it was observed that PCNA mRNA was found expressed in basal level as seen at 
(Figure 6A). However, after infection, cells had an initial increase of PCNA mRNA at 
day 6 pi matching peak of viremia, followed by a decrease of PCNA mRNA on day 20 
pi. Though it was not possible to continue to assess PCNA mRNA expression throughout 
the development of AIDS, it appears that all three animals used in this study had a similar 
trend of PCNA mRNA expression as seen up to 27 days after infection. When all animals 
were analyzed together, there was not a difference of expression levels of PCNA 
comparing to pre-infection (Figure 6B). 
 
 PCNA positive cells in SIVE lesions are mostly resident macrophages and not 
recently infiltrated monocytes. 
Animals 244-96, DB79 and 55-05 developed AIDS and SIVE and were used for 
histological analysis of PCNA. Within the CNS of these animals in approximate half of 
the cells in the lesions were PCNA+ (Figure 7) as previously described (66). The animals 
were injected with BrdU and regions of the CNS were double stained for PCNA and 
BrdU, PCNA and Mac387, and PCNA and CD163. Cell counts of single and double 
positives cells are shown in Table 2. The percentage of single PCNA positive cells in 
lesions is higher than the percentage of PCNA+ BrdU+ cells. Since monocytes do not 
divide in the blood (56), only the monocytes that are released from bone marrow after 
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BrdU injection can be labeled with BrdU. It is thought that only a small fraction of BrdU 
crosses the blood brain barrier (BBB) when injected intravenuously (55), and that free 
BrdU stays for only few hours in the CNS before being released to the cerebrospinal fluid 
(CSF) (24). Therefore, the BrdU+ monocyte-derived macrophages in the brain are 
representative of cells that incorporated BrdU in bone marrow prior to entering the CNS. 
The percentage of PCNA+ cells in lesions of animals that developed SIVE was not 
different among the animals studied, where the average was 44.5% positive cells of total 
lesion cells. However, animal DB79, which had BrdU injection at late stage of the 
disease (42 dpi and 48h prior necropsy) had less BrdU+ cells that contained PCNA, when 
compared with animals 244-96 and 55-05 that were injected with BrdU earlier and at 
multiple times after infection (Table 1). Results, therefore, show that there are few 
PCNA+BrdU+ cells in the CNS of DB79 because few cells migrated from bone marrow 
after BrdU injection at 42 pi, suggesting that PCNA expression in CNS macrophages is 
not related to recently migrated monocytes.  
Since BrdU was injected at multiple time points, Mac387, a marker of recently 
immigrated monocytes, was used to complete the analysis of recently immigrated 
monocytes. Single PCNA positive cells in lesions outnumbered the cells that were double 
positive for PCNA and Mac387, confirming the data from PCNA and BrdU double 
labeling. The number of PCNA+BrdU+ and PCNA+Mac387+ indicates that only 10-20% 
of PCNA expressing cells are BrdU or Mac387 positive. These data indicate that 
macrophages are induced to express PCNA in the CNS, after monocyte arrival to the 
tissue  (Table 2 and Figure 8). Double staining of PCNA and CD163 in animals that 
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developed SIVE (Figure 9) shows that most PCNA positive cells are CD163 positive 
macrophages (Table 2). This conclusion is inferred by the observation that the number of 
CD163 cells increases upon infection together with the number of CD68 cells when 
compared to uninfected animals (data not shown). 
When investigating PCNA function in the brain, Williams et al (66) stained the 
CNS for Ki-67 and did not find significant amount of cycling cells in lesions of SIVE 
monkeys. Since macrophages are terminally differentiated cells, Ki-67 labeling was 
expected to be negative. However the question still remains what the function of PCNA 
is in macrophages. To confirm that monocyte-derived macrophages of rhesus macaque 
do not divide, CD14+ monocytes were isolated from uninfected animals, cultured in 
chamber slides and pulsed with BrdU for analysis of PCNA and BrdU by 
immunohistochemistry (IHC). When CD14+ monocytes were cultured in adherent 
conditions and pulsed with BrdU, they did not incorporate BrdU unless cultured in the 
presence of M-CSF (Figure 10), however, the growth factor did not increase the number 
of cultured cells (data not shown). As a positive control, CEM cultured cells were pulsed 
with BrdU without any growth factor and results showed that 70% of cells were BrdU 
positive and 85% were PCNA positive (Figure 11). The single PCNA stained cells 
indicate a different stage of the cell cycle, other than the S phase (phase in which BrdU is 
incorporated into the cell).  
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DISCUSSION  
 
This study confirms previous results, which showed that the majority of PCNA 
positive cells in SIVE are CD68+ and CD16+ macrophages (19, 66). However, previous 
studies did not examine if monocytes express PCNA upon infection, which may become 
the PCNA+ cells seen in the CNS of Rhesus macaque. Here, it was hypothesized that 
upon SIV infection, monocytes could express PCNA and that the differentiation of 
monocytes to macrophages in tissue may induce re-entry into the cell cycle.  
Terai et al (56) demonstrated that DNA repair is a necessary mechanism for 
monocyte survival; therefore, a basal level of PCNA in these cells would be expected. 
When analyzed by quantitative real time PCR, PCNA expression was detected even prior 
to infection in the animals used (Figure 6). It was demonstrated by Vazquez et al (63) 
that HIV-infected monocyte-derived macrophages in vitro had an increase of PCNA 
expression seen by qRT-PCR, therefore, here it was expected to see an increase of PCNA 
expression upon SIV infection in rhesus. However, the level of PCNA mRNA expression 
was not different among the animals studied. 
 Flow cytometry analysis showed that uninfected and infected animals do not 
express detectable levels of PCNA in CD14+ monocytes. PCNA is known to interact with 
proteins that comprise the viral integration complex such as the transcription factor p300 
(4, 59, 63) and PCNA is found to be required for gap repairing of HIV cDNA integration 
intermediates in vitro (70). Therefore, it was hypothesized that upon SIV infection 
monocytes would express PCNA, which might directly affect viral integration in these 
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cells and show the productive infection in macrophages of the CNS. However, there was 
no PCNA expression in CD14+ monocytes in blood during progression to AIDS in rhesus 
monkeys (Figure 2). 
Even though monocytes are thought to bring virus to the CNS, there are few 
reports of productively infected monocytes in the blood (31). Only upon differentiation to 
macrophages in tissues that they are productively infected, (27). Upon differentiation to 
macrophages, monocytes undergo activation of multiple genes and this increase in 
transcription might require the breaking and rejoining of DNA, mechanisms in which 
PCNA would be expected to be involved (56, 62, 66). This thesis hypothesizes that upon 
differentiation of monocytes  to macrophages in tissues, they would express PCNA and 
that this differentiation might require monocytes to re-enter cell cycle. The results show 
that CD14+ monocytes had undetectable levels of the cell cycle marker Ki-67, indicating 
that they do not re-enter cell cycle in infected animals. When investigating the expression 
of BrdU+ monocytes in infected animals, it was observed that only 2% of monocytes 
contain BrdU in uninfected animals and the amount of BrdU positive cells only increased 
in rapid disease progressors (7). However, BrdU+ monocytes represented the 
incorporation of the thymidine homologue during the last division of monoblasts into 
monocytes in the bone marrow, before monocytes were released to the blood. In the same 
study, it was demonstrated that the increased turnover of monocytes from bone marrow 
was due to their migration into tissues to replenish apoptotic macrophages (23). In 
summary, the fact that BrdU+ monocytes incorporated BrdU before entering the blood, 
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and the lack of Ki-67 and PCNA expression in monocytes in blood suggest that 
monocytes do not re-enter cell cycle in SIV infected animals. 
Half of macrophages within lesions of SIVE animals were PCNA+ and the 
majority of these cells were SIV infected (66). Here it was hypothesized that PCNA 
positive cells from SIVE lesions were recently infiltrated monocytes bringing SIV and 
inducing PCNA expression in the CNS. This study demonstrates that the majority of 
PCNA cells within SIVE lesions are not recently migrated monocytes because only few 
PCNA positive cells were also BrdU and Mac387 positive (Table 2). BrdU and Mac387 
staining showed similar percentage of positive cells, however the number of single 
PCNA positive cells outnumbered the double positives for PCNA+BrdU+ or 
PCNA+Mac387+. In addition, at 21 days post-infection the number of Mac387 and BrdU 
positive cells is low in the CNS contrasting with the number of positive PCNA cells 
which are high in the infected animals. This study suggests that the expression of PCNA 
in macrophages of rhesus CNS is induced in resident cells rather than in recently 
migrated monocytes. This is in agreement with the data from flow cytometry showing 
undetectable levels of PCNA in monocytes, indicating that PCNA is expressed only upon 
monocyte arrival at the CNS.  
SIVE lesions were also stained for the hemoglobin scavenger receptor CD163, a 
monocyte/macrophage marker that may be involved in anti-inflammatory responses (14, 
44). The majority of PCNA positive cells were CD163+, confirming the identity of PCNA 
positive cells in SIVE lesions to be macrophages. CD163 is suggested to be present 
during monocyte/macrophage differentiation (30) and as discussed above, PCNA might 
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be involved in the increased chromosome arrangement characteristic of cell 
differentiation. The amount of CD163 cells in the CNS increase with the progression to 
disease as seen in Figure 9.   
We hypothesized that viral infection induces PCNA expression in SIVE as 
suggested by the majority of SIV RNA+PCNA+ or p28+PCNA+ cells in lesions (66). This 
study shows that single PCNA positive cells in the CNS of SIVE animals are also 
observed outside lesions, where no SIV protein (p28) is found and only few scattered SIV 
RNA are present. In addition, at 21 days post-infection only SIV RNA is detected in the 
CNS, however the number of single PCNA positives in the sections analyzed outnumbers 
the SIV RNA+PCNA+ cells. These data suggest a factor other than the presence of viral 
RNA or protein that induces PCNA in those cells.  In this study, the presence of viral 
cDNA was not examined, however PCNA+ cells might be SIV DNA+ representing 
latently infected cells. Previous studies have demonstrated SIV DNA in CNS 
macrophages in latent stages of the disease where no viral RNA or protein was found 
(13). Moreover, as mentioned above, there are a great amount of CD163+ cells as the 
animals develop SIVE. The amount of CD163-expressing cells in the CNS suggests that 
there might be secretion of cytokines in the CNS which may also induce the expression 
of PCNA. For instance, in glomerulonephritis, PCNA is induced in macrophages and its 
expression is in response to the growth factor M-CSF (28). 
Overall, this study demonstrates that monocytes do not express PCNA in the 
blood of uninfected or infected animals, indicating that monocytes do not express PCNA 
prior to entry into the CNS. This study also indicates that only few PCNA positive cells 
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in SIVE lesions are recently infiltrated macrophages, and suggests that the induction of 
PCNA occurs in CNS resident macrophages.  
 
FUTURE DIRECTIONS 
 
To complete the results of this study and for the understanding of PCNA 
induction in CNS macrophages of SIV infected animals, the next step would be to detect 
the co-localization of viral cDNA and PCNA in those cells.  Based in the fact that PCNA 
is involved in gap repairing of HIV cDNA integration intermediates in vitro (70) it is 
possible that SIV cDNA involves PCNA in its integration to the host genome. If there 
were SIV cDNA in those cells, it would indicate that viral DNA might be the factor that 
trigger PCNA expression in macrophages, probably by means of DNA repair, 
participating in the SIV cDNA integration to the host genome. If viral DNA is not found 
in PCNA positive cells that do not have either SIV RNA or protein, the next step would 
be to identify cytokines released in the CNS that can induce PCNA expression in 
macrophages. Together these studies will help to clarify what the function of PCNA is in 
SIV infected macrophages in the CNS. 
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Animal # Depleted* BrdU Injected Disease status 
28807 Long Term -9dpi, 7dpi, 26 dpi,24h pre-nec CMV/encephalitis 
16805 Long term -9dpi, 7dpi, 26 dpi,24h pre-nec AIDS no encephalitis 
5505 Long Term -9dpi, 7dpi, 26 dpi,24h pre-nec AIDS mild SIVE 
18605 Short Term -9dpi, 7dpi, 26 dpi,24h pre-nec >1 year no AIDS 
24496 Long Term -9dpi, 7dpi, 26 dpi,24h pre-nec AIDS severe SIVE 
    
3209 Long Term 12 and 26 dpi N/A 
3709 Long Term 12 and 26 dpi N/A 
6108 Long Term 12, 26 and 54 dpi N/A 
6608 Long Term 12, 26 and 54 dpi N/A 
    
4108 Long Term None N/A 
4208 Long Term None N/A 
6208 Long Term None N/A 
    
DB79 Long Term 48 dpi and 48h pre-nec AIDS SIVE 
FC32 Long Term 6 and 20 dpi Necropsy at 21dpi 
CR37 Long Term 6 and 20 dpi Necropsy at 21dpi 
Table 1: Summary of animals used in this study. Five animals (blue) were used for 
PBMC analysis by cytospin and brain histochemistry. Four animals (red) were used for 
the flow cytometry analysis, three animals (green) were used for the qRT-PCR and three 
animals (black) were used only for brain histochemistry studies. *The depleted column 
reflects how long the CD8+ lymphocytes were absent in the animals after infection of 
CD8 antibody. dpi, days post infection; nec, necropsy. N/A, pathology reports are not 
yet available. 
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  Animal 244-96 Animal DB79 Animal 55-05 
   %Mean ± SD   %Mean ± SD   %Mean ± SD 
PCNA+ cells  
vs. All cells  43.4 ± 7.4; n=36 46.8 ± 12.1; n=25 43.5 ± 8.7; n=6 
        
PCNA+ BrdU+ cells  
vs. all PCNA cells 12.5 ± 8.4; n=36 9.1 ± 6.4; n=25 6.8 ± 5.9; n=6 
        
PCNA+ MAC387+ cells 
vs all PCNA cells 11.5 ± 3.5; n=30 21  ± 16.4; n=16 19.1 ± 7.2; n=6 
        
PCNA+ CD163+ cells 
vs All PCNA cells 86.4 ± 6.1; n=39 88.9 ± 2.7; n=16 94.1 ± 6.8; n=5 
        
PCNA+ BrdU+ cells  
vs. all BrdU cells 49.6 ± 5.6; n=36 28.3 ± 17.7; n=25 54.2 ± 40.1; n=6 
        
PCNA+ Mac387+ cells  
vs. all Mac387 cells 23.3 ± 4.7; n=30 40.3 ± 5.9; n=16 40.3 ± 10.1; n=6 
        
PCNA+ CD163+ cells  
vs. all CD163 cells 45.4 ± 4.5; n=39 54.7 ± 2.3; n=16 41.5 ± 6.2; n=5 
Table 2: Percentage of PCNA double positive macrophages in SIVE. SIVE lesions from three 
animals were stained by IHC or IF and cells were counted as single or double stained for the 
markers. For animal 244-96 sections used were frontal cortex, occipital cortex, basal nuclei 
and frontal cortex; for animal DB79 were used sections from frontal cortex, basal nuclei, 
occipital and temporal cortex; for animal 55-05 only the section from thalamus contained 
lesions. n= Number of total lesions examined.  
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Figure 1: Gating strategy for identifying CD14+ monocytes and CD3+ lymphocytes in PBMC. 
PBMC freshly isolated from uninfected and infected blood were analyzed and monocyte 
gating strategy is shown for monocytes (A) and lymphocytes (B). Detection of monocytes 
was based in HLA-DR+CD3- population followed by confirmation of CD14 antigen. 
Lymphocyte population was gated by HLA-DR-CD3+ population (B) 
A 
B 
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Figure 2 PCNA is not expressed in CD14+ monocytes during progression to AIDS. CD14+ 
monocytes and CD3+ lymphocytes were gated as in Figure 1 and were stained with PCNA-
FITC on following time points: Uninfected (A, B), 13 days post-infection (C, D) and 55 days 
post-infection (E, F).  CD14+ cells did not express PCNA (A, C, E). CD3+ lymphocytes were 
used as a positive control.  Data is representative of 4 animals. 
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Figure 3: CEM cells as a positive control for PCNA staining. CEM cells were stained for 
Ki-67 and PCNA and used as positive control for PCNA staining. The majority of CEM 
cells in culture were viable as seen in the forward and side scatter (A) and were PCNA 
positive (B). 
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Figure 4: CD3+ lymphocytes are positive for PCNA. Cytospin preparations of PBMC were 
stained for CD3 and PCNA. About 40% of the cells were CD3 positive and 10% of total 
CD3+ cells were PCNA positive. Data is representative of 5 animals. A, overall staining 
results, B, a CD3+PCNA+ cell. CD3+ lymphocytes, brown, PCNA, red, hematoxylin, blue. 
A 
B 
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Figure 5: Monocytes do not enter cell cycle during AIDS progression. CD14+ monocytes and 
CD3+ lymphocytes were gated as in Figure 1 and were stained with Ki-67 PE at the same 
time points as Figure 2. A and B, pre infection; C and D, 13 days post-infection; E and F, 55 
days post-infection. Lymphocytes were used as positive control. Data are representative of 4 
animals. 
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Figure 6: PCNA mRNA expression does not increase in SIV infected animals. CD14+ 
monocytes were isolated at different time points after SIV infection and real time for PCNA 
was analyzed. Even though the levels of PCNA expression seems higher in few time points 
in individual animals (A), the overall data shows no increase in PCNA mRNA in monocytes 
of SIV infected animals. Data are representative of 3 animals. 
A 
B 
 
PCNA mRNA in monocytes of SIV infected animals (average)
6 12 20 27
0
1
2
3
4
5
Days post-infection
F
o
ld
 d
iff
e
re
n
c
e
 
re
la
tiv
e
 to
 d
a
y
0
 
0 
1 
2 
3 
4 
5 
6 
7 
6dpi 12dpi 20dpi 27dpi F
o
ld
 c
h
a
n
g
e
 r
e
la
ti
v
e
  
to
 d
a
y
 0
 
Days post-infection 
PCNA mRNA in SIV infected animals 
Animal 4108 
Animal 4208 
Animal 6208 
37|Page 
 
Figure 7. PCNA is not expressed in macrophages of uninfected animals. Uninfected animal (A) 
do not contain PCNA, while infected animal (B), contain many cells expressing PCNA in SIVE 
lesions and in perivascular cells. Hematoxylin, blue; PCNA, brown.  
 
A 
B 
38|Page 
 
 
 
 
 
 
 
 
 
 
 
 
                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: The majority of PCNA positive cells in CNS lesions are not recently migrated 
macrophages. Half of the cells in SIVE lesions are PCNA positive with about 6% of PCNA 
cells containing BrdU and about 15% being Mac387. (A) BrdU, brown; PCNA, red. (B) 
Mac387, brown; PCNA, red; Hematoxylin, blue. 
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Figure 9: CD163+ cells are the majority of PCNA positive cells in lesions. 80% of cells in 
lesions are CD163 positive cells with 26% of these cells being PCNA and CD163 double 
positive (`80% of PCNA positive cells). CD163, brown; PCNA, red; Hematoxylin, blue. 
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Figure 10: The majority of CD14+ monocyte-derived macrophages do not co-localize with 
BrdU in vitro. CD14+ cells were isolated from PBMC of uninfected animals and pulsed with 
BrdU in the presence of M-CSF. A, an overall of double stained cultured macrophages. 
PCNA, green; BrdU, red. B, graph showing the counting results. Data are representative of 5 
animals. 
20µm 
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Figure 11: CEM cells as a positive control for PCNA, showing different stages of cell cycle. 
CEM cells were incubated with BrdU for 5 hours prior to cytospin preparation. Experiment 
done in triplicate. (A) shows representative field of PCNA+ cells (green), BrdU+ cells (red), 
DAPI stained cells (blue) and PCNA+BrdU +double positives (yellow). B shows the percentage 
of each positive stained cells.  
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